Impact of breast cancer characteristics on the development and time to liver metastases: population-based study
BJS Open · 12.05.2026 · 10 (3)
DOI: 10.1093/bjsopen/zrag036 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJS Open, online erschienen am 12.05.2026. Verfasst von Marcus Sundén und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostics and Intervention, Surgery, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: Liver Neoplasms, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Breast Cancer Association, Region Västerbotten.
Abstract (Originalsprache)
Background
Breast cancer (Bc) is the leading cause of cancer-related death in women. In many patients, BC liver metastases (BCLM) are associated with short survival. The aims of this study were to investigate the risk of and time to BCLM in each BC surrogate subtype, and to determine the incidence of BCLM in a population-based setting.
Methods
The Swedish national breast cancer registry identified patients with Bc in a regional cohort from 2009 to 2018. The cohort was followed until January 2023. Cox regression analysis was used to determine the risk of BCLM for each subtype. Kaplan–Meier estimates determined the probability of BCLM for each subtype over time.
Results
In all, 7292 patients with Bc were included in the study. Distant metastases developed in 755 patients (10.4%); of these, 345 (45.7%) developed BCLM. The BCLM incidence rate was 8 per 1000 person-years. Only 13 patients had oligometastases isolated to the liver. Triple-negative, non-luminal human epidermal growth factor receptor 2 (HER2)-positive and luminal B cancers had the highest risk of BCLM. T category, nodal status, and Nottingham histological grade III were also strongly associated with BCLM. The median time from Bc diagnosis to BCLM was 36 months. Patients with HER2-positive BC subtypes developed BCLM early, at a median of only 9 months.
Conclusion
Bc subtype is correlated to the risk and timing of BCLM development. BCLM are common in advanced Bc, but isolated oligometastases are rare.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostics and Intervention, Surgery, Umeå University, Umeå, Sweden.
- Department of Diagnostics and Intervention, Oncology, Umeå University, Umeå, Sweden.
- Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
ORCID-Profile: Charlotta Wadsten, Malin Sund, Oskar Hemmingsson
Förderung
- Swedish Breast Cancer Association
- Region Västerbotten
Zitieren
APA
Sundén, M., Lindqvist, E., Wahlqvist, E., Hansson, E., Wadsten, C., Andersson, A., Sund, M., & Hemmingsson, O. (2026). Impact of breast cancer characteristics on the development and time to liver metastases: population-based study. BJS Open, 10(3). https://doi.org/10.1093/bjsopen/zrag036
Vancouver
Sundén M, Lindqvist E, Wahlqvist E, Hansson E, Wadsten C, Andersson A, et al. Impact of breast cancer characteristics on the development and time to liver metastases: population-based study. BJS Open. 2026;10(3). doi:10.1093/bjsopen/zrag036
BibTeX
@article{Sundn2026,
author = {Sundén, Marcus and Lindqvist, Elin and Wahlqvist, Ellen and Hansson, Ellen and Wadsten, Charlotta and Andersson, Anne and Sund, Malin and Hemmingsson, Oskar},
title = {Impact of breast cancer characteristics on the development and time to liver metastases: population-based study},
journal = {BJS Open},
year = {2026},
volume = {10},
number = {3},
doi = {10.1093/bjsopen/zrag036}
}
EUVIMED